Skip to content

Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases

Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030489
Enrollment
Unknown
Registered
2020-03-04
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

COVID-2019 patients in Tongji Hospital:none
COVID-2019 patients in Mobile field hospital:none
Medical staff in Tongji Hospital:none
Control:none

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. COVID-19 suspected or confirmed patients: meet the following suspected or confirmed case diagnostic criteria; aged between 18 and 70 years old; 1.1 Diagnostic criteria for suspected cases; 1.1.1 History of Epidemiology: (1) travel history or residence history within 14 days before the morbidity in Wuhan and its surrounding areas, or in other communities with reported cases; (2) History of contact with new coronavirus infection (positive nucleic acid test) within 14 days before morbidity; (3) Patients with fever or respiratory symptoms from Wuhan and its surrounding areas, or from communities with reported cases, had been contacted within 14 days before the morbidity; (4) Clustered morbidity (2 or more cases of fever and/or respiratory symptoms in a small area such as home, office, school class, etc. Within 2 weeks); 1.1.2 Clinical manifestations: (1) Fever and/or respiratory symptoms; (2) Having the above novel coronavirus pneumonia imaging features; (3) In the early stage of morbidity, the total number of white blood cells is normal or reduced, or the number of lymphocytes is normal or reduced; 1.1.3 Have any of the epidemiological history, and meet any 2 of the clinical signs. If there was no clear epidemiological history, it was in accordance with the 3 items in the clinical signs; 1.2 Diagnostic criteria for confirmed case Suspected cases also have one of the following etiological or serological evidence: (1) Detection of High Homology of Novel Coronavirus by Real-time Fluorescence RT-PCR; (2) Sequencing of the viral genome, which is highly homologous to known novel coronaviruses; (3) Serum specific IgM antibody and IgG antibody of new type coronavirus were positive; the specific IgG antibody of new type coronavirus in serum changed from negative to positive or increased by 4 times or more in recovery stage than in acute stage; 2. non-COVID healthy residents: Wuhan residents; non-COVID-2019 patients; 3. medical staff: age 18-70 years old and in-service hospital staff.

Exclusion criteria

Exclusion criteria: 1. COVID-19 suspected or confirmed patients: (1) Those who refuse to cooperate; (2) Pregnant women; (3)Patients with mental disorders and cognitive dysfunction. 2. non-COVID healthy residents: (1) Those who refuse to cooperate; (2) Patients with mental disorders and cognitive dysfunction. 3. medical staff: (1) Those who refuse to cooperate; (2) non-working staff; (3) Patients with mental disorders and cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
Nuclei acid test of SARS-CoV-2 of conjunctival swab;Nuclei acid test of SARS-CoV-2 of throat swab;Nuclei acid test of SARS-CoV-2 of peripheral blood sample;Eye symptoms;Clinical symptoms;

Secondary

MeasureTime frame
Previous eye diseases;Eye drop medication;Previous diseases;Chest CT;

Countries

China

Contacts

Public ContactXufang Sun

Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

s_1862777@163.com+86 18627770651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026